Search research articles
Contact Us
Filters
Showing results (51-60 of 61) with videos related to
Page
of 7
Sort By:
Bioorganic & Medicinal Chemistry Letters
|
February 6, 1999
Development of 2,2-dimethylchromanol cysteinyl LT1 receptor antagonists
R J Chambers, G W Antognoli, J B Cheng, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 1, 1995
The in vitro and in vivo pharmacologic activity of the potent and selective leukotriene B4 receptor antagonist CP-105696
H J Showell, E R Pettipher, J B Cheng, et al.
Journal of Physics. Condensed Matter : an Institute of Physics Journal
|
August 3, 2021
Unusual magnetization process and magnetocaloric effect in α-CoV<sub>2</sub>O<sub>6</sub>driven by pulsed magnetic fields
C B Liu, J B Cheng, J B He, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 6, 1999
Discovery of CP-199,330 and CP-199,331: two potent and orally efficacious cysteinyl LT1 receptor antagonists devoid of liver toxicity
R J Chambers, A Marfat, G W Antognoli, et al.
The Journal of Veterinary Medical Science
|
September 6, 2008
The effect of implanting an antigen release device on lactoferrin concentration in serum and milk
J B Cheng, J Q Wang, D P Bu, et al.
Clinical and Experimental Immunology
|
September 17, 2015
Monoclonal antibody against macrophage colony-stimulating factor suppresses circulating monocytes and tissue macrophage function but does not alter cell infiltration/activation in cutaneous lesions or clinical outcomes in patients with cutaneous lupus erythematosus
K Masek-Hammerman, E Peeva, A Ahmad, et al.
Journal of Medicinal Chemistry
|
February 17, 1998
Striking effect of hydroxamic acid substitution on the phosphodiesterase type 4 (PDE4) and TNF alpha inhibitory activity of two series of rolipram analogues: implications for a new active site model of PDE4
E F Kleinman, E Campbell, L A Giordano, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 5, 1999
N-carbamoyl analogs of Zafirlukast: potent receptor antagonists of leukotriene D4
M F Brown, A Marfat, G Antognoli, et al.
Journal of Medicinal Chemistry
|
January 5, 1996
Biarylcarboxylic acids and -amides: inhibition of phosphodiesterase type IV versus [3H]rolipram binding activity and their relationship to emetic behavior in the ferret
A J Duplantier, M S Biggers, R J Chambers, et al.
Journal of Medicinal Chemistry
|
June 19, 1998
7-Oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridines as novel inhibitors of human eosinophil phosphodiesterase
A J Duplantier, C J Andresen, J B Cheng, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 61) with videos related to
Sort By:
Page
of 7
Bioorganic & Medicinal Chemistry Letters
|
February 6, 1999
Development of 2,2-dimethylchromanol cysteinyl LT1 receptor antagonists
R J Chambers, G W Antognoli, J B Cheng, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 1, 1995
The in vitro and in vivo pharmacologic activity of the potent and selective leukotriene B4 receptor antagonist CP-105696
H J Showell, E R Pettipher, J B Cheng, et al.
Journal of Physics. Condensed Matter : an Institute of Physics Journal
|
August 3, 2021
Unusual magnetization process and magnetocaloric effect in α-CoV<sub>2</sub>O<sub>6</sub>driven by pulsed magnetic fields
C B Liu, J B Cheng, J B He, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 6, 1999
Discovery of CP-199,330 and CP-199,331: two potent and orally efficacious cysteinyl LT1 receptor antagonists devoid of liver toxicity
R J Chambers, A Marfat, G W Antognoli, et al.
The Journal of Veterinary Medical Science
|
September 6, 2008
The effect of implanting an antigen release device on lactoferrin concentration in serum and milk
J B Cheng, J Q Wang, D P Bu, et al.
Clinical and Experimental Immunology
|
September 17, 2015
Monoclonal antibody against macrophage colony-stimulating factor suppresses circulating monocytes and tissue macrophage function but does not alter cell infiltration/activation in cutaneous lesions or clinical outcomes in patients with cutaneous lupus erythematosus
K Masek-Hammerman, E Peeva, A Ahmad, et al.
Journal of Medicinal Chemistry
|
February 17, 1998
Striking effect of hydroxamic acid substitution on the phosphodiesterase type 4 (PDE4) and TNF alpha inhibitory activity of two series of rolipram analogues: implications for a new active site model of PDE4
E F Kleinman, E Campbell, L A Giordano, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 5, 1999
N-carbamoyl analogs of Zafirlukast: potent receptor antagonists of leukotriene D4
M F Brown, A Marfat, G Antognoli, et al.
Journal of Medicinal Chemistry
|
January 5, 1996
Biarylcarboxylic acids and -amides: inhibition of phosphodiesterase type IV versus [3H]rolipram binding activity and their relationship to emetic behavior in the ferret
A J Duplantier, M S Biggers, R J Chambers, et al.
Journal of Medicinal Chemistry
|
June 19, 1998
7-Oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridines as novel inhibitors of human eosinophil phosphodiesterase
A J Duplantier, C J Andresen, J B Cheng, et al.
Page
of 7